The imprinted Igf2 gene is active only on the paternal allele in most tissues. Its imprinting involves a cis-acting imprinting-control region (ICR) located upstream of the neighboring and maternally expressed H19 gene. It is thought that differential methylation of the parental alleles at the ICR is crucial for parental imprinting of both genes. Differentially methylated regions (DMRs) have also been identi®ed within the Igf2 gene and their differential methylation is thought to be established during early development. To gain further insight into the function of these DMRs, we performed a quantitative analysis of their allelic methylation levels in different tissues during fetal development and the postnatal period in the mouse. Surprisingly, we found that the methylation levels of Igf2 DMRs vary extensively during fetal development, mostly on the expressed paternal allele. In particular, in skeletal muscle, differential allelic methylation in both DMR 1 and DMR 2 occurs only after birth, whereas correct paternal monoallelic expression is always observed, including in the embryonic stages. This suggests that differential methylation in the DMR 1 and DMR 2 of the Igf2 gene is dispensable for its imprinting in skeletal muscle. Furthermore, progressive methylation of the Igf2 paternal allele appears to be correlated with concomitant postnatal down-regulation and silencing of the gene. We discuss possible relations between Igf2 allelic methylation and expression during fetal development. q
Introduction
Igf2 and H19 are two imprinted genes separated by 90 kb on chromosome 7 in the mouse. H19 is expressed exclusively from the maternal allele (Bartolomei et al., 1991) whereas Igf2 expression is restricted to the paternal allele (DeChiara et al., 1991) . From a recent series of experiments, it has been suggested that imprinting at this locus is a direct consequence of allelic methylation in a 2 kb sequence, the imprinting-control region (ICR), located 2 kb upstream of the H19 gene (Bell and Felsenfeld, 2000; Hark et al., 2000; Kanduri et al., 2000; Szabo et al., 2000; Thorvaldsen et al., 1998) . Its differential methylation originates from the gametes (Tremblay et al., 1997; and consequently, the ICR is often called a`germ-line differentially methylated region'. CTCF, a zinc ®nger protein implicated in vertebrate insulator activity (Bell et al., 1999) , binds to the unmethylated maternal allele and activates the boundary function of this element (Bell and Felsenfeld, 2000; Hark et al., 2000; Kanduri et al., 2000; Szabo et al., 2000) which prevents a common set of enhancers (Leighton et al., 1995) , located downstream of H19 (Yoo-Warren et al., 1988) , from interacting with the Igf2 promoters. On the paternal allele, methylation prevents binding of CTCF to the ICR allowing Igf2 expression whereas the H19 gene is silenced (Drewell et al., 2000; Srivastava et al., 2000) .
Differentially methylated regions (DMRs) have also been described in the Igf2 locus. Two of these DMRs (DMR 1 and DMR 2) are located within the Igf2 gene (Fig. 1A) and are preferentially methylated on the paternal allele (Brandeis et al., 1993; Feil et al., 1994) while a third (DMR 0), located upstream of the gene, is preferentially methylated on the maternal allele and is restricted to the placenta (Moore et al., 1997) . The methylation patterns of DMR 1 and 2 have been shown to vary according to the tissue (Brandeis et al., 1993; Feil et al., 1994) and are thought to be established www.elsevier.com/locate/modo during early embryogenesis (Hsieh, 2000; Reik and Walter, 1998; Shemer et al., 1996) . Furthermore, using 9.5 dpc (days post-coõ Ètum) mutant mouse embryos carrying a deletion of the maintenance methyltransferase gene dnmt-1 (Li et al., 1993) , it has been demonstrated that expression of the Igf2 gene does not necessarily require its own DNA methylation (Jones et al., 1998) . Finally, a recent work shows that Igf2 DMR 1 is a silencer element in several mesodermal tissues, but not in skeletal muscle .
Here we used Southern blot and PhosphorImager analyses to quantify the allelic methylation levels of DMR 1 and DMR 2 in different tissues during fetal mouse development. We found that allelic methylation levels in Igf2 DMRs vary not only in a tissue-speci®c manner but are also extensively altered during the perinatal period. These variations occur in some but not all tissues without affecting Igf2 monoallelic expression.
Results

A methodology to accurately quantify allelic methylations in the Igf2/H19 locus
To quantify allelic methylation levels, we used a methodology based on digestion of genomic DNA with methylation sensitive restriction enzymes and PhosphorImager analysis of Southern-blots (see Fig. 1 and Section 4). The advantage of this technique is that numerous samples can easily be analyzed simultaneously and that the results reliably re¯ect the mean methylation level of a CpG in the cellular population of the sample. We took advantage of the extensive bisulphite studies already published on the methylation at the Igf2/H19 locus (Feil et al., 1994; Forne Â et al., 1997; Oswald et al., 2000; Tremblay et al., 1997; Warnecke et al., 1998) to choose methylation sensitive enzymes which allow the study of CpGs whose mean methylation levels have been shown to be representative of the entire DMR in which they are located (see Table 1 and Section 4).
We ®rst carried out an experiment to assess the accuracy and reliability of this methodology. A total of 44 DNA samples from newborn and 2 day old mouse liver were assayed for methylation in the Igf2 DMR1 and H19 gene body. Standard deviations for the mean methylation levels on both alleles were consistently between 3 and 5% whatever the DMR or the developmental stage (data not shown). This methodology has thus proved to be very accurate and reliable in measuring the allelic methylation levels in the Igf2 and H19 genes.
Dynamics of allelic methylation of the Igf2 DMR 1 and DMR 2 during fetal development
We analyzed the tissue-speci®c allelic methylation patterns of DMR 1 and DMR 2 of the Igf2 gene during fetal mouse development (Fig. 1B) . Results obtained for ®ve tissues (liver, heart, kidney, muscle and tongue) are shown in Fig. 2 .
On the maternal allele, the methylation of both DMRs is relatively constant during fetal development but its level varies considerably depending on the tissue. For example, in DMR 1 the mean methylation level of the maternal allele is 19% in liver, but 51% in muscle, and in DMR 2 it is 18% in kidney, but 42% in heart ( Fig. 2A,B) . However, in kidney the DMR 1 methylation level increases signi®cantly from 26% in 15.5 dpc embryos to 56% in 18 day old mice (Fig.  2A) .
On the Igf2 paternal allele, hypermethylation throughout fetal development is found for the DMR 2 in liver (Fig. 2B ) and for the DMR 1 in heart and in kidney ( Fig. 2A) . Conver- . Quanti®cations are performed with a PhosphorImager. For DMR1 (left), the CpG dinucleotide studied is located in a Nae1 restriction site. Genomic DNA is digested with Xba1, Dra1 and with (1) or without (2) Nae1 (Turbo Nae1, Promega). Probe 1 is a 0.58 kb Xba1-Nae1 fragment and restriction fragments detected are shown. The example shows DNA prepared from 10 day old mouse liver. For DMR 2 (right), the CpG dinucleotide is located in a Fsp1 restriction site. Genomic DNA is digested with BamH1, EcoN1 and with (1) or without (2) Fsp1. Probe 2 is a 0.65 kb Fsp1-BamH1 fragment in exon 6. The example shows DNA prepared from 2 day old mouse liver. (C) Methylation analysis in the ICR and the H19 gene. A restriction map of the H19 gene region is shown. Allelic methylation is quanti®ed using the same strategy as explained above. For the ICR (left), the CpG dinucleotide is located in an Ava1 restriction site. Genomic DNA is digested with Sac1, BamH1 and with (1) or without (2) Ava1. Probe 3 is a 0.62 kb Ava1-BamH1 fragment. The example shows DNA prepared from 18.5 dpc embryo muscle. For the H19 promoter (top), the CpG dinucleotide is located in a Sma1 restriction site. Genomic DNA is digested with Bgl1, Sph1 and with (1) or without (2) Sma1. Probe 4 is a 0.63 kb BamH1-Bgl1 fragment in exon 1. The example shows DNA prepared from 18 day old mouse liver. For the H19 gene (right), two CpG dinucleotides located in two adjacent Sma1 restriction sites in exon 5 are studied. Genomic DNA is digested with Bgl1 and with (1) or without (2) Sma1. Probe 5 is a 0.87 kb Bgl1-Sma1 fragment in exons 1±5. The example shows DNA prepared from 2 day old mouse tongue. : Maternal allele;
: paternal allele. *Polymorphic restriction site speci®c for Mus spretus. 8CpG-methylation sensitive restriction enzyme. A, Ava1; B, BamH1; Bg, Bgl1; D, Dra1; E, EcoN1; F, Fsp1; N, Nae1; S, Sac1; Sm, Sma1; Sp, Sph1; X, Xba1. Tremblay et al. (1997) . b Feil et al. (1994) . c Oswald et al. (2000) . d Oswald and Walter, pers. com. e Forne Â et al. (1997) .
sely, in all other instances, this allele is susceptible to significant variations as we found that it undergoes progressive methylation during fetal development. In the DMR1 the paternal methylation level increases in liver from 44% in 12.5 dpc embryos to 94% in 18 day old mice ( Fig. 2A ). Between 15.5 dpc and postnatal day 18, it increases from 33 to 98% in tongue and from 37 to 100% in muscle ( Fig.  2A ) whereas in the DMR 2 it increases from 14 to 94% in tongue and from 42 to 86% in muscle (Fig. 2B ). In the latter two tissues, we observe a striking burst of methylation on the Igf2 paternal allele in both DMRs around birth.
The above experiments reveal two peculiar situations in tongue and muscle before birth where the maternal Igf2 allele is almost equally ( Fig. 2A and muscle Fig. 2B ) or even more methylated (tongue Fig. 2B ) than the paternal allele. These unusual allelic methylation patterns in skeletal muscle tissues result from both a particularly high methylation level of the maternal allele and an extremely low methylation level of the paternal allele. After birth the familiar methylation patterns, with the paternal allele more methylated than the maternal allele, are progressively established.
Finally, as a control, we analyzed the allelic methylation levels in the`germ-line DMR' upstream of H19 (Fig. 1C ).
As expected (Tremblay et al., 1995; , allelic methylation levels are stable regardless of the tissue and developmental stage with hypermethylation of the paternal allele and complete unmethylation of the maternal allele (Fig.  2C ).
Absence of differential allelic methylation in both DMRs of the Igf2 gene in skeletal muscle tissues does not affect its monoallelic expression
Since we found unusual methylation patterns and a striking allelic methylation switch in the Igf2 gene in skeletal muscle tissues, we determined whether its monoallelic expression was affected. To that aim, we extracted total RNAs from muscle and tongue and assayed the Igf2 allele-speci®c expression by RT-PCR (Fig. 3A) . In both tissues, the monoallelic expression of the Igf2 gene from the paternal allele is maintained throughout development (Fig. 3B) . We conclude that the absence of differential allelic methylation in the Igf2 DMRs in skeletal muscle tissues does not affect the correct monoallelic expression of the gene. In liver, where the allelic methylation pattern in the DMR1 is extensively altered during development ( Fig. 2A) , Fig. 2 . Dynamics of allelic methylation of Igf2 DMRs during fetal mouse development. Allelic methylation levels have been quanti®ed during fetal mouse development in DMR1 (A), DMR2 (B) and the ICR (C). DNA samples from 12.5 dpc (liver) or 15.5 dpc (heart, kidney, muscle and tongue) embryos to 18 day old mice have been treated and analyzed by Southern blot as described in Fig. 1 . Quanti®cations were performed by PhosphorImager analysis as described in Section 4. Graphs show the dynamics of methylation of the paternal (black squares) and maternal (open circles) alleles during fetal development. Standard deviations were calculated from data obtained from two liver samples (DMR1) and from three (DMR1) or two (DMR2) samples for both muscle and tongue. 29, 12.5 dpc embryos; 26, 15.5 dpc embryos; 23, 18.5 dpc embryos; 0, birth; 3±18, 3±18 day old mice. paternal monoallelic expression also remains unaffected (data not shown).
Tissue-speci®c expression of the Igf2 gene during fetal development in the mouse
Since we found that the methylation levels of the expressed paternal allele of the mouse Igf2 gene vary extensively in some tissues during fetal development, we considered the possibility that these changes in methylation levels may be related to changes in Igf2 expression levels.
To that aim, we quanti®ed by Northern-blots the Igf2 mRNA levels in the same tissue samples (liver, heart, kidney, muscle, tongue). Fig. 4A shows the results of these quanti®cations after normalization against 18S rRNA levels (see Section 4). As expected (Soares et al., Fig. 3 . Igf2 imprinting in skeletal muscle tissues is not altered by the allelic methylation switch in DMR1 and 2 during fetal mouse development. (A) Igf2 allelic expression is assayed by RT-PCR on total RNA prepared from F1 individuals (Mus musculus domesticus £ SD7). PCR is carried out in the coding exons 4±6 common to all Igf2 transcripts. The 602 bp PCR product is restricted with BsaA1, a polymorphic restriction enzyme speci®c for the Mus spretus allele, and loaded on agarose gels. On the right, the control shows RT-PCR on total RNA from M.m.domesticus (lanes 2±4) and M.spretus (lanes 5± 7) before (2) and after (1) digestion with BsaA1. Lanes 2 and 5 are control RT-PCR without reverse transcriptase. MW, Molecular Weight (100 bp ladder). (B) Igf2 paternal expression in muscle and tongue is not altered during fetal development. RT-PCR has been carried out on muscle and tongue RNA from 15.5 dpc embryos to 18 day old mice. For each sample, the control RT-PCR without reverse transcriptase and RT-PCR before (2) and after (1) digestion with BsaA1 are shown. 26, 15.5 dpc embryos; 23, 18.5 dpc embryos; 0, birth; 3±18: 3±18 day old mice. Fig. 4 . Tissue-speci®c expression of Igf2 during fetal mouse development. Igf2 gene expression was assayed by Northern blot analysis in ®ve tissues (liver, heart, kidney, muscle and tongue). For each tissue, 10 mg of total RNA extracted from 15.5 dpc embryos to 18 day old mice were loaded onto formaldehyde/1% agarose gels and hybridized with an Igf2 3 H UTR speci®c probe which reveals simultaneously all three Igf2 transcripts (see Section 4). (A) Quanti®cation of Igf2 mRNA levels during fetal mouse development. Northern blot signals were quanti®ed by PhosphorImager analysis and normalized against the amount of 18S rRNA. The relative amount of total Igf2 transcripts is expressed in arbitrary units. 26, 15.5 dpc embryos; 23, 18.5 dpc embryos; 0, birth; 3±18, 3±18 day old mice. (B) Comparison of Igf2 gene transcript expression in mouse tissues by Northern blot analysis. The 4.8 kb transcript is derived from promoter 2 and the 3.8 kb transcripts from promoter 1 or 3 . The 1.7 kb fragment results from a cleavage in the 3 H UTR of the transcripts. The positions of 18S and 28S rRNA are indicated. L, liver (newborns); H, heart (15.5 dpc embryos); K, kidney (15.5 dpc embryos); M, muscle (18.5 dpc embryos); T, tongue (18.5 dpc embryos).
1986), the highest expression levels are observed nearly 8 days after birth in liver and around birth in tongue and muscle. In heart and kidney transcript levels decrease during fetal development, suggesting that the maximum of expression occurs before 15.5 dpc. No expression of the Igf2 gene is detected in any of the tissues in 18 day old mice. We have shown elsewhere in run-on experiments from murine liver and muscle samples that the abundance of Igf2 mRNA, as determined here in Northern-blots, is a faithful image of the transcriptional activity of the gene (Milligan et al., 2000) . Three Igf2 mRNAs are expressed in the mouse embryo resulting from differential promoter usage: P1 (~3.9 kb), P2 (4.8 kb) or P3 (3.8 kb). In addition, some mRNAs are cleaved in the 3 H UTR to give a stable 1.7 kb fragment (de Pagter- Holthuizen et al., 1988; Meinsma et al., 1991) . The Igf2 4.8 and 3.8 kb transcripts are detected in all tissues except the liver where no signi®cant level of P2 transcript is detected (Fig. 4B) . In tissues expressing both the 4.8 and 3.8 kb transcripts, their relative amounts vary concomitantly (data not shown). The 1.7 kb fragment is detected in all tissues except liver ( Fig. 4B ) and thus may be related to the presence of the Igf2 P2 transcript.
Comparison between Igf2 expression levels and methylation analyses of DMR 1 and DMR 2 enables us to make the following observations. In cases where the methylation level of the paternal allele is modi®ed during fetal development (DMR 1 in liver, muscle and tongue; DMR 2 in heart, kidney, muscle and tongue) paternal hypermethylation is associated with down-regulation and silencing of the gene. Furthermore, in muscle and tongue, methylation changes appear correlated with changes in Igf2 expression, as the striking burst of methylation observed on the paternal allele around birth in both Igf2 DMRs occurs when gene expression begins to be strongly down-regulated (compare Fig.  2A ,B with Fig. 4) . Conversely, hypermethylation of the paternal allele observed throughout fetal development on DMR 1 in kidney and heart and on DMR 2 in liver appears to be independent of concomitant Igf2 expression levels.
Dynamics of allelic methylation at the H19 locus
Finally, since the Igf2 and H19 genes are reciprocally imprinted and co-expressed during development (Lee et al., 1990; Poirier et al., 1991) , we analyzed the dynamics of allelic methylation in the H19 promoter and gene body (for technical procedure see Fig. 1C ).
In the H19 promoter, allelic methylation levels, as those in the`germ-line DMR', were found to be stable throughout development in liver and muscle (data not shown). The paternal allele is always highly methylated (around 70%) and the maternal allele remains completely unmethylated. Thus, this methylation pattern re¯ects the imprinted status of the gene. Further downstream within the H19 gene body, allelic methylation levels were found to be more variable (data not shown). On the paternal allele, the methylation level increases in liver during fetal development whereas a substantial decrease is observed in tongue. On the maternal allele, methylation remains at low levels although somē uctuations were detected in liver, heart and kidney. Thesē uctuations do not correlate with gene expression levels (data not shown). However, contrary to Igf2, in the H19 gene body a substantial differential methylation consistent with the imprinted status of the gene is maintained in all tissues.
Discussion
In this work, we show that the differential methylation of both Igf2 DMRs varies extensively in a tissue-speci®c manner during fetal development, in particular in skeletal muscle tissue where, unexpectedly, differential methylation occurs only after birth. However, the absence of differential methylation does not affect maintenance of the correct monoallelic expression of the gene. Moreover, we found that the variations of methylation level on the paternal allele are associated with changes in expression levels of the gene. Signi®cantly, hypermethylation of the paternal allele in Igf2 DMRs is ultimately associated with a transcriptionally silent gene in 18 day old mice.
One interesting aspect of our work is to demonstrate that a methodology based on DNA digestion by methylationsensitive restriction enzymes and quanti®cation by Southern-blots is very powerful and accurate to quantify the mean allelic methylation levels of CpGs at imprinted loci in a cellular population. However, quanti®cations are restricted to a single CpG and its choice is critical if the results are to be extrapolated to the entire DMR. It is therefore important to note that, for each DMR, we took advantage of numerous previous bisulphite data to choose CpGs whose methylation levels are representative of the mean methylation level of the whole DMR (see Table 1 and Section 4).
A striking result is that the methylation levels in the Igf2 DMRs are profoundly altered on the expressed paternal allele during fetal development in the mouse. Indeed, numerous studies have previously suggested that the methylation at imprinted loci may vary during embryogenesis (Brandeis et al., 1993; Feil et al., 1994; Shemer et al., 1996) , but, with few exceptions (Liu et al., 2000; Stoger et al., 1993) , it is generally assumed that these differential methylation patterns are set up during early development or at the latest at the time of implantation (Hsieh, 2000; Reik and Walter, 1998) . Our results show that this is not necessarily the case for either of the DMRs in the Igf2 gene. The methylation level of the Igf2 maternal allele seems to be fairly stable, but the methylation level of the expressed Igf2 paternal allele increases in many tissues during organogenesis in the mouse. Our observations also show that the regulation of allelic methylation levels of the DMR 1 can be very different from that of DMR 2 in the same tissue during development; this is particularly obvious in the liver (compare Fig. 2A with Fig. 2B) . Furthermore, the variations of the methylation levels in Igf2 DMRs are themselves very different from those at the H19 locus (data not shown). This strongly suggests that these variations re¯ect regional regulation con®ned to speci®c DMRs rather than global changes that would affect the whole locus. However coordinate regulation of methylation of both Igf2 DMRs can be suspected in some tissues such as muscle and tongue ( Fig. 2A,B) .
In skeletal muscle tissues, a preferential paternal methylation is acquired only after birth, as differential methylation is either insigni®cant or reversed in the embryo (Fig. 2A,B) . However, correct monoallelic expression is observed in these tissues (Fig. 3B) . This leads us to conclude that the absence of differential allelic methylation in both Igf2 DMRs does not affect the maintenance of the monoallelic expression in tongue and muscle and suggests that, at least in these tissues, differential methylation in DMR 1 and 2 is dispensable for Igf2 imprinting. Interestingly, a novel Igf2 repressor element has recently been identi®ed in the mouse . This repressor lies 40 kb downstream of the Igf2 gene and is required for proper maintenance of Igf2 imprinting in skeletal muscle tissues, including tongue. This ®nding is consistent with the proposal that DMR 1 and DMR 2 may not be involved in Igf2 imprinting in muscle and tongue, as suggested by our work.
Our ®ndings are also in agreement with the work of Constancia et al. (2000) showing that deletion of the DMR 1 sequences in mouse leads to loss of imprinting of the Igf2 gene in mesodermal tissues, except in muscle. Indeed, we observed that, during fetal development, paternal methylation patterns of the DMR 1 are modi®ed only in tissues where this DMR is not required for Igf2 imprinting (liver and skeletal muscle) . Conversely, in several mesodermal tissues (heart and kidney), paternal hypermethylation of this DMR is maintained throughout development independently of Igf2 expression. This is in agreement with the hypothesis that DMR 1 is a mesodermal Igf2 repressor inactivated on the paternal allele by DNA methylation . There is growing evidence that elements involved in Igf2 imprinting act in a tissue-speci®c manner Constancia et al., 2000) . If the above considerations about DMR 1 can be extrapolated to DMR 2, we may predict that, while the DMR 2 does not play an important role in Igf2 imprinting in skeletal muscle, it may be required in liver, and perhaps in some mesodermic tissues (heart, kidney), since the DMR 2 paternal allele is found hypermethylated throughout development only in these tissues. This observation is also reminiscent of our previous ®nding that, in mice carrying H19 gene deletions, the DMR 2 on the Igf2 paternal allele is much less prone to methylation changes in liver than in other tissues (Forne Â et al., 1997) .
Our results strengthen the idea that paternal methylation of DMRs is required for Igf2 gene expression in some tissues. Nevertheless, in tongue and muscle, up-regulation of Igf2 gene expression occurs while methylation levels of the paternal allele on both Igf2 DMRs are very low ( Fig.  2A,B) . Thus, in these tissues, Igf2 expression does not appear to need its own DNA methylation and this may reinforce the conclusions of Jones et al. (Jones et al., 1998) . However, the Igf2 paternal allele is never completely unmethylated and thus we cannot exclude that Igf2 expression may require a minimal methylation level.
Finally, in skeletal muscle tissues, we show that the increase in the methylation level of the Igf2 paternal allele ( Fig. 2A,B) occurs simultaneously with Igf2 postnatal down-regulation (Fig. 4A) . In this case, one possibility is that hypermethylation of the paternal allele is involved in Igf2 silencing although this would be dif®cult to conciliate with its postulated role in promoting Igf2 expression in other tissues . Alternatively, methylation could be simply a consequence of transcriptional downregulation. However, progressive methylation of the paternal allele in the DMR1 in liver ( Fig. 2A) occurs during transcriptional up-regulation (Fig. 4) and therefore the methylation is not a consequence of down-regulation in this tissue. Finally, it is interesting to note that methylation levels in the Igf2 promoters and enhancers remain low throughout development and the postnatal period (Bartolomei et al., 1993; Sasaki et al., 1992 ; Weber, unpublished results) and thus they cannot account for down-regulation of the gene. Of course, trans-acting factors which speci®cally target these transcriptional regulatory elements may also be involved in that process.
Experimental procedures
Compilation of data from bisulphite analyses
We compiled data from available bisulphite analyses to assess the representativeness of the methylation levels of individual CpGs relative to the whole DMR in which they are located. For the three DMRs we studied, the CpGs analyzed are indeed representative, as the ratios between their methylation levels and those of the whole DMR are close to 1 in all tissues and at all developmental stages investigated (Table 1) .
DNA preparation
As a general procedure, Mus musculus domesticus C57BL/6J £ CBA F1 females were mated to SD7 males (SD7 is a C57BL/6J £ CBA strain containing the distal portion of Mus spretus chromosome 7). Tissues were dissected from F1 progenies from 12.5 dpc (liver) or 15.5 dpc (kidney, heart, tongue and muscle) embryos to 18 day old neonates. All embryonic samples were collected from two litters and postnatal samples from three individuals. One half of each sample was used to extract DNA for methylation analyses and the other was frozen for subsequent RNA extractions. For some tissues, additional sets of sample were prepared from other individuals to repeat some experiments and calculate standard deviations (see legend to Fig. 2) . For DNA extractions, tissues were disrupted in solution A (75 mM NaCl, 25 mM EDTA, pH 8.0) using a Dounce homogenizer, an equal volume of solution B (10 mM Tris±HCl pH 8.0, 10 mM EDTA, 1% SDS) was added and overnight digestion was performed at 558C with proteinase K (®nal concentration: 0.2 mg/ml). Genomic DNA was puri®ed by two phenol extractions and one chloroform/isoamylalcohol (24v/1v) extraction followed by isopropanol precipitation.
Quanti®cation of allelic methylation levels by Southern analysis
Quanti®cation of allelic methylation levels is based on Southern analysis of genomic DNA digested by CpG methylation sensitive restriction enzymes. The detailed procedure for methylation analysis in each of the DMRs studied in this work is given in the legend to Fig. 1 . Taking advantage of restriction polymorphisms between Mus musculus and Mus spretus species, we ®rst digested DNA samples with appropriate restriction enzymes unaffected by DNA methylation allowing to distinguish the parental origin of the restriction fragments. Half of each sample was restricted with a suitable methylation sensitive enzyme (see legend to Fig. 1 ). Samples digested with or without the methylation sensitive enzyme were electrophoresed on 1.5% agarose gels (20 mg per lane), transferred to a nylon membrane (Nytran-SPC, Schleicher & Schuell) and hybridized with a speci®c probe (Fig. 1) . Hybridization and washes were performed as described by Church and Gilbert (Church and Gilbert, 1984) . Signals were quanti®ed using a PhosphorImager apparatus (ImageQuaNT software, Molecular Dynamics). Values were carefully corrected by subtracting the local background and were normalized to the total amount of material loaded in the lane. This methodology allows to accurately quantify the mean methylation levels of the CpG analyzed for each parental allele in the cellular population of the sample. Data were ®nally plotted onto graphs as shown in Fig. 2. 
RNA preparation and Northern analysis
Tissue samples were disrupted in a guanidinium thiocyanate solution using a Dounce homogenizer. Subsequent total RNA extraction was carried out using acidic phenol/chloroform followed by isopropanol precipitation. Finally samples were re-extracted with phenol (pH 7.5) and chloroform and precipitated with ethanol.
For Northern analysis, total RNAs were electrophoresed on a 1.1% agarose gel containing 20 mM sodium phosphate buffer (pH 7.0), 1 mM EDTA and 2 M formaldehyde. The gel was soaked for 30 min in 50 mM NaOH, 10 mM NaCl, rinsed twice for 20 min in 150 mM ammonium acetate and transferred onto nylon membrane (Appligene Oncor) in 150 mM ammonium acetate. Hybridization was carried out at
